Abstract
We investigated the capacity of Mycoplasma arthritidis mitogen (MAM) to induce (a) expression of the inducible enzymes cyclo-oxygenase (COX-2) and nitric oxide synthase (iNOS), (b) production of prostaglandin E2 (PGE2) and nitric oxide (NO), and (c) involvement of platelet-activating factor (PAF) in the MAM-induced activation pathway. Resident peritoneal cells from C3H/HePas mice were incubated with MAM in the presence or absence of a PAF-antagonist (WEB2170) or COX-2 inhibitors (nimesulide or NS398). Enzyme expression was evaluated by immunoblotting, PGE2 by EIA, and NO by Griess reaction. Following MAM-stimulation of peritoneal cells, expression of COX-2 was detected at 3 h (peak levels at 12 h) and of iNOS at 6 h (peak levels at 20 h). PGE2 increased till 20 h, decreasing thereafter, whereas NO increased with time. WEB2170 (5 x 10(-5) M) treatment caused 44% inhibition of NO output and reduced iNOS expression (48% at the peak of expression). Concomitant treatment with WEB2170 and nimesulide (10(-5) M) reversed these inhibitory effects. WEB2170 reduced COX-2 expression (43% at the peak of expression) and prevented the decline in PGE2 levels after 20 h. These results suggest the involvement of PAF in the signaling pathway trig...Continue Reading
References
Jun 1, 1987·Agents and Actions·E R PettipherB Henderson
Sep 9, 1982·Nature·D S SnyderE R Unanue
Feb 1, 1995·British Journal of Pharmacology·A A SteilL Bosca
Apr 1, 1995·British Journal of Pharmacology·T A SwierkoszJ R Vane
Aug 1, 1993·The Journal of Experimental Medicine·N McCartney-FrancisS M Wahl
Dec 1, 1993·Circulation Research·C SzabóJ R Vane
Nov 1, 1993·European Journal of Immunology·S HauschildtP Scheipers
Aug 15, 1994·FEBS Letters·H Kaur, B Halliwell
Mar 1, 1994·The Journal of Clinical Investigation·L J CroffordT Hla
Jun 1, 1995·Clinical and Experimental Pharmacology & Physiology·J F ArthurG J Dusting
Jan 9, 1998·Shock·E A ChristB K English
May 23, 1998·Annual Review of Pharmacology and Toxicology·J R VaneR M Botting
Nov 24, 1999·Prostaglandins & Other Lipid Mediators·W W LinS K Shyue
May 2, 2000·The Journal of Biological Chemistry·L J MarnettJ D Morrow
Jun 2, 2000·Immunobiology·A HendricksH J Schuberth
Oct 18, 2000·Infection and Immunity·M V LonardoniS Jancar
Jun 11, 2002·British Journal of Pharmacology·José C da S RochaFrancisco A C da Rocha
Citations
Oct 12, 2007·Biotechnology Letters·Mi-Hyun HwangSeung-Chun Park
Nov 29, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Ana T GuerreroThiago M Cunha
Oct 30, 2008·Microbes and Infection·Marina Tiemi ShioFátima Ribeiro-Dias
Dec 19, 2007·European Journal of Immunology·Tanapat PalagaBarbara A Osborne
Jul 19, 2006·Prostaglandins & Other Lipid Mediators·Soraya Imon de OliveiraSonia Jancar
Jan 14, 2016·PloS One·Ruoshuang ZhangDong Lin
Mar 12, 2021·Virulence·Chen YiwenYou Xiaoxing
Sep 28, 2021·Food & Function·Naunpun SangphechSiriporn Chuchawankul